scholarly article | Q13442814 |
P50 | author | Tsuyoshi Tajima | Q88015638 |
Yoshiki Asayama | Q88575700 | ||
H Honda | Q88632968 | ||
Akihiro Nishie | Q89914901 | ||
Kenji Shinozaki | Q90748176 | ||
Kengo Yoshimitsu | Q92455532 | ||
Hiroyuki Irie | Q114021196 | ||
Mitsuo Shimada | Q114289696 | ||
Tomohiro Nakayama | Q116781293 | ||
Daisuke Kakihara | Q116781294 | ||
Hitoshi Aibe | Q117226343 | ||
P2093 | author name string | Shin-Ichi Aishima | |
Kisaku Yoshida | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cholangiocarcinoma | Q124292 |
P1104 | number of pages | 6 | |
P304 | page(s) | 1157-1162 | |
P577 | publication date | 2005-04-01 | |
P1433 | published in | American Journal of Roentgenology | Q15752879 |
P1476 | title | Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings | |
P478 | volume | 184 |
Q52629233 | A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma. |
Q38465673 | Biphenotypic hepatic tumors: imaging findings and review of literature |
Q34975197 | Cancer stem cells in primary liver cancers: pathological concepts and imaging findings. |
Q42177616 | Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery |
Q40379545 | Combined hepatocellular and cholangiocarcinoma with sarcomatoid transformation: radiologic-pathologic correlation of a case. |
Q37316850 | Combined hepatocellular and cholangiocellular carcinoma presenting with radiological characteristics of focal nodular hyperplasia |
Q35936570 | Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography |
Q38481613 | Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma: outcome after liver transplantation |
Q51326232 | Combined hepatocellular carcinoma-cholangiocarcinoma: report of MR appearance in eleven patients. |
Q53479218 | Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging. |
Q39016627 | Combined hepatocellular-cholangiocarcinoma: Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis |
Q53083641 | Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma. |
Q36732055 | Combined hepatocholangiocarcinoma: case-series and review of literature |
Q38445643 | Comparison between resection and transplantation in combined hepatocellular and cholangiocarcinoma. |
Q38587512 | Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging |
Q46379419 | Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review. |
Q38723527 | Imaging spectrum of cholangiocarcinoma: role in diagnosis, staging, and posttreatment evaluation |
Q57112805 | Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma |
Q48156461 | Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma |
Q34823616 | Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma |
Q38497061 | Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma |
Q46059132 | The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma |
Q37605862 | Uncommon liver tumors: Case report and literature review |
Q33844564 | Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma |
Q48513742 | cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. |
Search more.